U.S., Jan. 14 -- An application to own the trademark for 'XPRYVI' has been filed on Jul. 22, 2025.
Owner(s):
Leadiant Biosciences, Inc.; 530 Gaither Rd., Suite 300, , MARYLAND
Goods and/or Services:
For: Pharmaceutical preparations for the treatment of eye diseases and conditions; Ocular pharmaceuticals
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2026-01-13&serialNumber=99296468
Disclaimer: Curated by HT Syndication....